Variables | Total No. of patients (n = 114) | FMNL2 expression | χ2 | P-value | |
---|---|---|---|---|---|
Negative (n = 80) | Positive (n = 34) | ||||
Age | Â | Â | Â | 1.565 | 0.211 |
  < 50 | 65 | 47 | 18 |  |  |
  ≥ 50 | 49 | 30 | 19 |  |  |
histopathological type | Â | Â | Â | 0.814 | 0.665 |
 Invasive ductal carcinoma | 111 | 78 | 33 |  |  |
 Ductal carcinoma in situ | 2 | 1 | 1 |  |  |
 Invasive lobular carcinoma | 1 | 1 | 0 |  |  |
Clinical stage | Â | Â | Â | 5.48 | 0.065 |
 1 | 14 | 12 | 2 |  |  |
 2 | 48 | 37 | 11 |  |  |
 3 | 52 | 31 | 21 |  |  |
TNM phase | Â | Â | Â | 0.329 | 0.567 |
 I-II | 65 | 47 | 18 |  |  |
 III-IV | 49 | 33 | 16 |  |  |
Ki67 | Â | Â | Â | 11.668 | 0.001* |
  < 14% | 44 | 39 | 5 |  |  |
  ≥ 14% | 70 | 41 | 29 |  |  |
Tumor size | Â | Â | Â | 0.495 | 0.482 |
  < 2 cm | 32 | 24 | 8 |  |  |
  ≥ 2 cm | 82 | 56 | 26 |  |  |
ER status | Â | Â | Â | 6.327 | 0.012* |
 ER (−) | 29 | 15 | 14 |  |  |
 ER (+) | 85 | 65 | 20 |  |  |
PR status | Â | Â | Â | 2.173 | 0.14 |
 PR (−) | 42 | 26 | 16 |  |  |
 PR (+) | 72 | 54 | 18 |  |  |
HER2 status | Â | Â | Â | 0.31 | 0.578 |
 HER2 (−) | 36 | 24 | 12 |  |  |
 HER2 (+) | 78 | 56 | 22 |  |  |